Canceled by the investigator Lipi Guben Decoction in Treating Diarrheal Irritable Bowel Syndrome: a study protocol for a randomized controlled trial
- Conditions
- Irritable bowel syndrome
- Registration Number
- ITMCTR2100004403
- Lead Sponsor
- The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. According to the IBS diagnostic criteria of Western medicine, the patients with diarrhea as the main type and the patients with liver depression and spleen deficiency syndrome, spleen stomach weakness syndrome and liver depression and qi stagnation syndrome of traditional Chinese medicine.
2. Patients willing to sign informed consent.
3. Patients aged from 18 to 65 years.
1. Pregnant or preparing for pregnancy, lactating women.
2. Patients with intestinal organic diseases, such as inflammatory bowel disease, intestinal tuberculosis and colonic polyps;
3. Patients with severe diseases of cardiovascular and cerebrovascular system, liver, kidney, hematopoietic system and tumors;
4. Patients with digestive tract operation records;
5. Patients with serious primary diseases and psychosis;
6. Patients with allergic history or drug and food allergy during the test period;
7. Patients who did not meet the inclusion criteria, did not use drugs according to the regulations, could not judge the efficacy or incomplete information, which affected the efficacy or safety judgment.
8. Patients considered unsuitable for this clinical trial.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TCM syndrome curative effect;
- Secondary Outcome Measures
Name Time Method Quality of Life Questionnaire (IBS-QOL);IBS symptom severity scale;